Capricor Therapeutics Inc [NASDAQ: CAPR] surged by $2439992.32 during the normal trading session on Tuesday and reaching a high of $9.3538 during the day while it closed the day at $2440000.0.
Capricor Therapeutics Inc stock has also loss -25.28% of its value over the past 7 days. However, CAPR stock has declined by -30.35% in the 3 months of the year. Over the past six months meanwhile, it has lost -26.12% and gained 94.33% year-on date.
The market cap for CAPR stock reached $422.80 million, with 45.68 million shares outstanding and 40.15 million shares in the current float. Compared to the average trading volume of 2.44M shares, CAPR reached a trading volume of 8767259 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Capricor Therapeutics Inc [CAPR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CAPR shares is $38.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CAPR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Roth Capital have made an estimate for Capricor Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 20, 2025. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on October 21, 2024, representing the official price target for Capricor Therapeutics Inc stock. Previously, the target price had yet another raise to $14, while Oppenheimer analysts kept a Outperform rating on CAPR stock.
The Price to Book ratio for the last quarter was 3.31, with the Price to Cash per share for the same quarter was set at 3.17.
CAPR stock trade performance evaluation
Capricor Therapeutics Inc [CAPR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -25.28. With this latest performance, CAPR shares dropped by -14.83% in over the last four-week period, additionally sinking by -26.12% over the last 6 months – not to mention a drop of -32.97% in the past year of trading.
Capricor Therapeutics Inc [CAPR]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Capricor Therapeutics Inc [CAPR] shares currently have an operating margin of -329.90% and a Gross Margin at 91.37%. Capricor Therapeutics Inc’s Net Margin is presently recorded at -317.13%.
Return on Equity for this stock declined to -54.19%, with Return on Assets sitting at -54.19%.
Capricor Therapeutics Inc [CAPR]: Institutional Ownership
There are presently around $40.97%, or 49.24% of CAPR stock, in the hands of institutional investors. The top three institutional holders of CAPR stocks are: BLACKROCK INC. with ownership of 1.63 million shares, which is approximately 5.1145%. VANGUARD GROUP INC, holding 1.55 million shares of the stock with an approximate value of $$7.39 million in CAPR stocks shares; and VANGUARD GROUP INC, currently with $$3.06 million in CAPR stock with ownership which is approximately 2.0149%.
